Homepage
Author:
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Posted Date:
May 13, 2026
Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
May 13, 2026
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
April 28, 2026
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
April 28, 2026
Fosun Pharma Announces 2025 Annual Results
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
March 24, 2026
